Viewing Study NCT00540592


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-01-07 @ 1:36 PM
Study NCT ID: NCT00540592
Status: COMPLETED
Last Update Posted: 2018-06-08
First Post: 2007-10-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-10-08
Start Date Type: None
Primary Completion Date: 2008-06-10
Primary Completion Date Type: ACTUAL
Completion Date: 2008-06-10
Completion Date Type: ACTUAL
First Submit Date: 2007-10-05
First Submit QC Date: None
Study First Post Date: 2007-10-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2012-04-26
Results First Submit QC Date: None
Results First Post Date: 2012-05-30
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2009-09-30
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2018-05-09
Last Update Post Date: 2018-06-08
Last Update Post Date Type: ACTUAL